Device and method for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology

The preparation of polylactic acid microspheres containing stereocomposite crystals using microfluidic technology solves the problems of non-uniform microsphere size and insufficient crystal performance in existing technologies, and achieves controllable microsphere size and improved performance.

CN118904223AActive Publication Date: 2024-11-08QUZHOU RES INST OF ZHEJIANG UNIV +1
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410981585.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-08
Estimated Expiration
2044-07-22

AI Technical Summary

Technical Problem

Existing methods for preparing polylactic acid microspheres result in microspheres with inconsistent size and poor morphology. Furthermore, when using L-polylactic acid as a raw material, the resulting homocrystalline material has a low melting point, insufficient modulus, and inadequate hydrolysis resistance.

Method used

Microfluidic technology was employed to prepare polylactic acid microspheres containing stereocomposite crystals using microfluidic devices, microinjection pumps, syringes, and droplet size adjustment tubes. The stereocomposite crystals were formed by utilizing the shearing effect of the dual-channel injection tube and the shape adjustment of the droplet size adjustment tube.

Benefits of technology

The prepared polylactic acid microspheres have controllable size and uniform particle size, and have higher melting point, modulus and hydrolysis resistance. The content of stereocomposite crystals can be adjusted.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118904223A_ABST
    Figure CN118904223A_ABST
Patent Text Reader

Abstract

The invention discloses a device and a method for preparing polylactic acid microspheres containing stereocomplex crystals based on a micro-fluidic technology. The device comprises a micro-injection pump, an injector, a liquid drop size adjusting tube, an evaporating dish, a glass substrate, an oil-phase sample injection needle, a water-phase sample injection needle, a double-channel injection tube and a square tube, the end parts of the square tube and the liquid drop size adjusting tube are communicated and are fixed on the glass substrate; the evaporating dish is placed below the liquid drop size adjusting pipe; the double-channel injection tube is drawn by a double-channel capillary tube, the end part of the double-channel injection tube is polished into a conical structure and is centrally inserted into the square tube, and the water-phase sample injection needle is inserted into the square tube and fixed at the joint of the square tube and the double-channel injection tube; the two oil phase sample injection needles are respectively inserted and fixed in two channels of the double-channel injection tube; the liquid drop size adjusting tube is a teflon microtube with a bend. The polylactic acid microspheres prepared by the preparation method disclosed by the invention are controllable in size, uniform in particle size, monodisperse, higher in melting point and modulus and better in hydrolysis resistance.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of preparation of polylactic acid microspheres, and in particular to a device and method for preparing polylactic acid microspheres containing stereocomposite crystals based on microfluidic technology. Background Art

[0002] Polylactic acid is a bio-based polyester that has a wide range of applications in food, medicine, agriculture, etc. due to its good biodegradability and biocompatibility. Among them, microspheres prepared from polylactic acid have the advantages of adjustable size, large surface area, and good dispersibility, and have been used in cutting-edge fields such as beauty, drug delivery, and embolization therapy.

[0003] Generally speaking, polylactic acid microspheres are prepared by homogeneous emulsification-solvent evaporation technology. However, the microspheres obtained by the existing preparation methods of polylactic acid microspheres are more dispersed in size and have poor microsphere morphology. In addition, the common polylactic acid microspheres are all made of left-handed polylactic acid (PLLA) as raw materials, and form homogeneous crystals during solvent evaporation and crystallization. Homogeneous crystals have a lower melting point and poor modulus and hydrolysis resistance. Summary of the invention

[0004] In view of the shortcomings of the prior art, based on the microfluidic technology developed in recent years, the present invention proposes a device and method for preparing polylactic acid microspheres containing stereocomposite crystals based on microfluidic technology. The specific technical scheme is as follows:

[0005] A device for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology, the device comprising a microfluidic device, a microinjection pump, a syringe, a droplet size adjustment tube and an evaporating dish;

[0006] The microfluidic device comprises a glass substrate, an oil phase injection needle, a water phase injection needle, a dual-channel injection tube, and a square tube; the square tube is connected to the end of the droplet size adjustment tube, and both are fixed on the glass substrate; the evaporating dish is placed under the droplet size adjustment tube to collect polylactic acid droplets;

[0007] The dual-channel injection tube is centrally inserted into the square tube; the dual-channel injection tube is a dual-channel capillary tube drawn and polished to form a tapered structure at the end, and the diameter of a single channel at the end of the tapered structure of the dual-channel injection tube is 50-300 μm; the water phase injection needle is inserted into the square tube and fixed at the junction of the square tube and the dual-channel injection tube; the two oil phase injection needles are respectively inserted and fixed in the two channels of the dual-channel injection tube;

[0008] There are three micro-injection pumps and three syringes, and the syringes are arranged on the micro-injection pumps one by one. The three micro-injection pumps are used to pump the surfactant solution as the water phase, the left-handed polylactic acid solution as the oil phase one, and the right-handed polylactic acid solution as the oil phase two, respectively; the outlet of the syringe for pumping the water phase is connected to the water phase injection needle; and the two syringes for pumping the oil phase are connected to the two oil phase injection needles, respectively;

[0009] The droplet size regulating tube is a polytetrafluoroethylene microtube with bends.

[0010] Furthermore, the bends of the droplet size adjustment tube are any one of sinusoidal, triangular, square and spiral, or the cross section of the droplet size adjustment tube along the droplet flow direction is a variable cross section.

[0011] Furthermore, the droplet size adjustment tube has no less than 2 bends.

[0012] A method for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology, the method is implemented based on the above-mentioned preparation device, and the method comprises the following steps:

[0013] Step 1: dissolving L-polylactic acid and D-polylactic acid in volatile organic solvents to prepare oil phase 1 and oil phase 2 with a mass percentage of 5 to 15 wt % respectively; dissolving a surfactant in deionized water to obtain a water phase with a mass percentage of 1 to 5 wt %;

[0014] Step 2: Load the water phase into the corresponding syringe, use a micro-injection pump for pumping the water phase to inject the water phase into the square tube through the water phase injection needle, load the oil phase 1 and the oil phase 2 into the corresponding syringes respectively, use a micro-injection pump for pumping the oil phase to inject the oil phase 1 and the oil phase 2 into the double-channel injection tube through two oil phase injection needles; at the outlet of the double-channel injection tube, polylactic acid droplets are obtained due to shearing action;

[0015] Step 3: Collect the prepared polylactic acid droplets through the droplet size adjustment tube, and place them in a room temperature air environment to allow the organic solvent to completely evaporate to obtain polylactic acid microspheres; then wash the polylactic acid microspheres with deionized water for multiple times, and freeze-dry to obtain polylactic acid microspheres of uniform size.

[0016] Furthermore, the organic solvent is dichloromethane or chloroform.

[0017] Furthermore, the surfactant is polyvinyl alcohol, polysorbate and polyvinyl pyrrolidone.

[0018] Furthermore, the flow rate of the oil phase in the dual-channel injection tube is 0.5-1 mL / h, and the flow rate of the water phase in the square tube is 2.5-7.5 mL / min.

[0019] Furthermore, in the step three, the volatilization time is prolonged, and the content of stereocomplex crystals in the formed polylactic acid microspheres is increased.

[0020] Furthermore, the first oil phase is prepared by dissolving L-polylactic acid in dichloromethane to obtain a 10 wt % solution, and the second oil phase is prepared by dissolving D-polylactic acid in dichloromethane to obtain a 10 wt % solution.

[0021] Furthermore, the flow rate of the oil phase in the dual-channel injection tube is 0.5 mL / h, and the flow rate of the water phase in the square tube is 7.5 mL / min.

[0022] The beneficial effects of the present invention are as follows:

[0023] The device for preparing polylactic acid microspheres containing stereocomposite crystals of the present invention can prepare polylactic acid microspheres with controllable size, uniform particle size, and monodispersity. In addition, the polylactic acid microspheres containing stereocomposite crystals prepared by the device of the present invention have a higher melting point, a higher modulus, and better hydrolysis resistance than existing polylactic acid microspheres, and the content of stereocomposite crystals contained in the polylactic acid microspheres is adjustable. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 It is a schematic structural diagram of a device for preparing polylactic acid microspheres containing stereocomposite crystals based on microfluidic technology according to an embodiment of the present invention.

[0025] Figure 2 This is a magnified image of the dual-channel injection tube under a microscope.

[0026] Figure 3 Schematic diagram of droplet size adjustment tubes with different cross-sectional shapes.

[0027] Figure 4 Wide-angle X-ray diffraction patterns of microspheres collected for droplet size adjustment tubes with different square wave numbers.

[0028] Figure 5 Wide-angle X-ray diffraction patterns of microspheres at different volatilization rates.

[0029] Figure 6 This is a differential scanning calorimetry test result diagram of stereostructured crystalline microspheres and homogeneous crystalline microspheres.

[0030] Figure 7 This is a comparison chart of the modulus of stereostructured crystalline microspheres and homogeneous crystalline microspheres.

[0031] Figure 8This is a statistical diagram of the size distribution of polylactic acid microspheres.

[0032] In the figure, 1 is a glass substrate, 2 is a dual-channel injection tube, 3 is a square tube, 4 is an aqueous phase injection needle, 5 is an oil phase injection needle, 6 is a droplet size adjustment tube, 7 is a microinjection pump, 8 is a syringe, 9 is an injection microtube, and 10 is an evaporating dish. DETAILED DESCRIPTION

[0033] The present invention will be described in detail below based on the accompanying drawings and preferred embodiments, and the purpose and effects of the present invention will become more clear. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0034] like Figure 1 As shown, the device of this embodiment for preparing polylactic acid microspheres containing stereocomposite crystals based on microfluidic technology includes a glass substrate 1, a dual-channel injection tube 2, a square tube 3, an aqueous phase injection needle 4, an oil phase injection needle 5, a droplet size adjustment tube 6, a microinjection pump 7, a syringe 8, an injection microtube 9 and an evaporating dish 10.

[0035] Among them, the glass substrate 1, the dual-channel injection tube 2, the square tube 3, the water-phase injection needle 4, and the oil-phase injection needle 5 constitute a microfluidic device, the dual-channel injection tube 2 is inserted into the square tube 3, the dual-channel injection tube 2 is a dual-channel capillary formed by drawing and polishing a dual-channel capillary with a conical structure at the end, and the diameter of a single channel at the end of the conical structure of the dual-channel injection tube is 50-300 μm. The square tube 3 and the droplet size adjustment tube 6 are connected at the end, and both are fixed on the glass substrate 1. The evaporating dish 10 is placed below the droplet size adjustment tube 6 to collect polylactic acid droplets containing stereocomplex crystals. The water-phase injection needle 4 is inserted into the square tube 3 and fixed at the junction of the square tube 3 and the dual-channel injection tube 2; the two oil-phase injection needles 5 are respectively inserted and fixed in the two channels of the dual-channel injection tube 2.

[0036] There are three microinjection pumps 7 and three syringes 8. The three syringes 8 are arranged on the three microinjection pumps 7 in a one-to-one correspondence. The three microinjection pumps 7 are respectively used to pump the surfactant solution as the water phase, the left-handed polylactic acid solution as the oil phase one, and the right-handed polylactic acid solution as the oil phase two; the outlet of the syringe for pumping the water phase is connected to the water phase injection needle 4; the two syringes for pumping the oil phase are respectively connected to the two oil phase injection needles 5.

[0037] Among them, the surfactant solution as the aqueous phase is a polyvinyl alcohol aqueous solution with a mass percentage of 1 to 5wt% formed by dissolving polyvinyl alcohol in deionized water; the left-handed polylactic acid solution as the oil phase one is a solution of 5 to 15wt% by dissolving left-handed polylactic acid in dichloromethane, preferably a solution of 10wt%; the right-handed polylactic acid solution as the oil phase two is a solution of 5 to 15wt% by dissolving right-handed polylactic acid in dichloromethane, preferably a solution of 10wt%.

[0038] like Figure 1 and Figure 2 As shown, the water phase injection needle 4 in this embodiment is a syringe needle, which is connected to the corresponding syringe through the injection microtube 9. The oil phase injection needle 5 is a slender flat stainless steel needle, so it can be directly connected to the corresponding syringe. Figure 3 As shown, the bends of the droplet size adjustment tube are any one of a sine wave type, a triangular wave type, a square wave type, and a spiral type, or the cross section of the droplet size adjustment tube along the flow direction of the droplet is a variable cross section. As the droplets flow in the flow channels of the droplet size adjustment tubes of different shapes, they will be mixed to different degrees due to the secondary flow inside the droplets, forming different contents of stereocomposite crystals, so that the content of the stereocomposite crystals can be adjusted by adjusting the bend shape and the number of bends of the droplet size adjustment tube.

[0039] As another embodiment, this embodiment provides a method for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology. The method is implemented based on the above-mentioned preparation device and includes the following steps:

[0040] Step 1: dissolving L-polylactic acid and D-polylactic acid in volatile organic solvents to prepare oil phase 1 and oil phase 2 with a mass percentage of 5 to 15 wt % respectively; dissolving a surfactant in deionized water to obtain a water phase with a mass percentage of 1 to 5 wt %;

[0041] Step 2: Load the water phase into the corresponding syringe, use a micro-injection pump for pumping the water phase to inject the water phase into the square tube through the water phase injection needle, load the oil phase one and the oil phase two into the corresponding syringes respectively, use a micro-injection pump for pumping the oil phase to inject the oil phase one and the oil phase two into the double-channel injection tube through two oil phase injection needles; at the outlet of the double-channel injection tube, polylactic acid droplets are obtained due to shearing; wherein, the flow rate of the oil phase in the double-channel injection tube is 0.5-1 mL / h, and the flow rate of the water phase in the square tube is 2.5-7.5 mL / min.

[0042] Step 3: Collect the prepared polylactic acid droplets through the droplet size adjustment tube, and place them in a room temperature air environment to allow the organic solvent to completely evaporate to obtain polylactic acid microspheres; then wash the polylactic acid microspheres with deionized water for multiple times, and freeze-dry to obtain polylactic acid microspheres of uniform size.

[0043] Example 1

[0044] (1) Weigh 0.4 g of left-handed polylactic acid PLLA and right-handed polylactic acid PDLA, respectively, and dissolve them in 4 g of dichloromethane to form the oil phase. The solution is drawn into a 10 mL syringe, and the syringe is fixedly mounted on a microinjection pump.

[0045] (2) Weigh 1.5 g of polyvinyl alcohol and dissolve it in 30 g of deionized water at 40°C with stirring as the aqueous phase. Suck the solution into a 30 mL syringe and fix the syringe on a microinjection pump. The droplet size adjustment tube 6 is a tube bent into a square wave shape.

[0046] (3) The flow rate of the oil phase microinjection pump was set to 0.5 mL / h, and the flow rate of the water phase microinjection pump was set to 7.5 mL / min. Polylactic acid droplets were obtained by shearing. The polylactic acid droplets were collected by a level adjustment tube and placed in an air environment at room temperature to allow the dichloromethane to completely evaporate. The microspheres were then washed multiple times with deionized water and freeze-dried to obtain polylactic acid microspheres of uniform size with an average diameter of 265 μm.

[0047] In order to study the effect of the number of square waves of the droplet size adjustment tube 6 on the content of stereocomposite crystals, the droplet size adjustment tube 6 with 1 square wave, 3 square waves and 5 square waves was used for experiments. The content of stereocomposite crystals was characterized by wide-angle X-ray diffraction. The results are shown in FIG. Figure 4 As the number of square waves increases, the diffraction peak of the homogeneous crystal gradually weakens, and the diffraction peak of the stereocomposite crystal gradually strengthens, proving that the content of stereocomposite crystals in the microspheres can be regulated by adjusting the number of square waves in the flow channel.

[0048] Furthermore, in order to verify the effect of volatilization time on the content of stereocomplex crystals in the formed polylactic acid microspheres, 30, 60, 120, 300, and 600 polylactic acid microspheres were placed in the evaporating dish, and the wide-angle X-ray diffraction patterns of the microspheres at different volatilization rates were obtained, as shown in FIG. Figure 5 As shown, from Figure 5 It can be seen that as the number of PLA microspheres increases, the evaporation rate of the organic solvent slows down, the mixing degree of L-PLA molecules and D-PLA molecules in the droplets increases, and the content of stereocomplex crystals in the formed PLA microspheres decreases. Therefore, extending the evaporation time can increase the content of stereocomplex crystals in the formed PLA microspheres.

[0049] Comparative Example 1

[0050] (1) Weigh 0.8 g of poly (L-lactic acid) PLLA and dissolve it in 4 g of dichloromethane as the oil phase. Suck the solution into a 10 mL syringe and fix the syringe on a microinjection pump.

[0051] (2) Weigh 1.5 g of polyvinyl alcohol and dissolve it in 30 g of deionized water at 40°C with stirring as the aqueous phase. Suck the solution into a 30 mL syringe and fix the syringe on a microinjection pump. The droplet size adjustment tube 6 is a tube bent into a square wave shape.

[0052] (3) The flow rate of the oil phase microinjection pump is set to 0.5 mL / h, and the flow rate of the water phase microinjection pump is set to 7.5 mL / min. Polylactic acid droplets are obtained by shearing. The polylactic acid droplets are collected by a level adjustment tube and placed in an air environment at room temperature to allow the dichloromethane to completely evaporate. The microspheres are then washed multiple times with deionized water and freeze-dried to obtain polylactic acid microspheres of uniform size.

[0053] The heat changes of the microspheres obtained in Example 1 and Comparative Example 1 during the heating process were measured using a differential scanning calorimeter. The results are as follows: Figure 6 As shown, from Figure 6 It can be seen that the melting point of polylactic acid microspheres containing stereocomposite crystals is 221.7°C, while the melting point of polylactic acid microspheres with homogeneous crystals is 173.1°C. The formation of stereocomposite crystals significantly increases the melting point of polylactic acid microspheres.

[0054] The compression modulus of the polylactic acid microspheres obtained in Example 1 and Comparative Example 1 was tested. The results are as follows: Figure 7 As shown, from Figure 7 It can be seen that the compression modulus of the polylactic acid microspheres containing stereocomposite crystals is 565.1 MPa, while the compression modulus of the polylactic acid microspheres with homogeneous crystals is 1068.0 MPa. The formation of stereocomposite crystals significantly increases the melting point of the polylactic acid microspheres.

[0055] Example 2

[0056] Steps (1) and (2) are the same as in Example 1. In step (3), the flow rate of the oil phase microinjection pump is set to 0.5 mL / h, and the flow rate of the water phase microinjection pump is set to 2.5 mL / min. The final average diameter of the microspheres obtained is 768 μm.

[0057] Example 3

[0058] Steps (1) and (2) are the same as in Example 1. In step (3), the flow rate of the oil phase microinjection pump is set to 1 mL / h, and the flow rate of the water phase microinjection pump is set to 7.5 mL / min. The final average diameter of the microspheres obtained is 363 μm.

[0059] Example 4

[0060] Steps (1) and (2) are the same as in Example 1. In step (3), the flow rate of the oil phase microinjection pump is set to 1 mL / h, and the flow rate of the water phase microinjection pump is set to 2.5 mL / min. The final average diameter of the microspheres obtained is 947 μm.

[0061] Example 5

[0062] Steps (1) and (2) are the same as in Example 1. In step (3), the flow rate of the oil phase microinjection pump is set to 0.5 mL / h, and the flow rate of the water phase microinjection pump is set to 5 mL / min. The final average diameter of the microspheres obtained is 410 μm.

[0063] Example 6

[0064] Steps (1) and (2) are the same as in Example 1. In step (3), the flow rate of the oil phase microinjection pump is set to 1 mL / h, and the flow rate of the water phase microinjection pump is set to 5 mL / min. The final average diameter of the microspheres obtained is 561 μm.

[0065] The relationship between the microsphere size obtained in Examples 1 to 6 and the flow rates of water and oil phases is shown in Table 1.

[0066] Table 1 Relationship between microsphere size and water and oil phase flow rate

[0067]

[0068] It can be seen from Table 1 that the size of the final polylactic acid microspheres can be adjusted by adjusting the flow rates of the water phase and the oil phase. The standard deviation of the microsphere sizes of Examples 1 to 6 is small. Figure 8 It can be seen that the size distribution of microspheres is concentrated and monodispersity is good.

[0069] Example 7

[0070] Steps (1) and (2) are the same as in Example 1, wherein the surfactant in step (2) is replaced by polyvinyl pyrrolidone. In step (3), the flow rate of the oil phase microinjection pump is set to 0.5 mL / h, and the flow rate of the water phase microinjection pump is set to 7.5 mL / min.

[0071] Example 8

[0072] Steps (1) and (2) are the same as in Example 1, wherein the surfactant in step (2) is replaced by polysorbate. In step (3), the flow rate of the oil phase microinjection pump is set to 0.5 mL / h, and the flow rate of the water phase microinjection pump is set to 7.5 mL / min.

[0073] Example 9

[0074] Steps (1) and (2) are the same as in Example 1, wherein the organic solvent in step (1) is replaced by chloroform. In step (3), the flow rate of the oil phase microinjection pump is set to 0.5 mL / h, and the flow rate of the water phase microinjection pump is set to 7.5 mL / min.

[0075] Those skilled in the art can understand that the above are only preferred examples of the invention and are not intended to limit the invention. Although the invention is described in detail with reference to the above examples, those skilled in the art can still modify the technical solutions recorded in the above examples or replace some of the technical features therein with equivalents. Any modification, equivalent replacement, etc. made within the spirit and principle of the invention shall be included in the protection scope of the invention.

Claims

1. A device for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology, characterized in that: The device comprises a microfluidic device, a microinjection pump, a syringe, a droplet size adjustment tube and an evaporating dish; The microfluidic device comprises a glass substrate, an oil phase injection needle, a water phase injection needle, a dual-channel injection tube, and a square tube; the square tube is connected to the end of the droplet size adjustment tube, and both are fixed on the glass substrate; the evaporating dish is placed under the droplet size adjustment tube to collect polylactic acid droplets; The dual-channel injection tube is centrally inserted into the square tube; the dual-channel injection tube is a dual-channel capillary tube drawn and polished to form a tapered structure at the end, and the diameter of a single channel at the end of the tapered structure of the dual-channel injection tube is 50-300 μm; the water phase injection needle is inserted into the square tube and fixed at the junction of the square tube and the dual-channel injection tube; the two oil phase injection needles are respectively inserted and fixed in the two channels of the dual-channel injection tube; There are three micro-injection pumps and three syringes, and the syringes are arranged on the micro-injection pumps one by one. The three micro-injection pumps are used to pump the surfactant solution as the water phase, the left-handed polylactic acid solution as the oil phase one, and the right-handed polylactic acid solution as the oil phase two, respectively; the outlet of the syringe for pumping the water phase is connected to the water phase injection needle; and the two syringes for pumping the oil phase are connected to the two oil phase injection needles, respectively; The droplet size regulating tube is a polytetrafluoroethylene microtube with bends.

2. The device for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology according to claim 1, characterized in that: The bends of the droplet size adjustment tube are any one of sinusoidal wave, triangular wave, square wave and spiral, or the cross section of the droplet size adjustment tube along the droplet flow direction is a variable cross section.

3. The device for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology according to claim 1, characterized in that: The droplet size adjustment tube has no less than 2 bends.

4. A method for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology, characterized in that: The method is implemented based on the preparation device according to claim 1, and the method comprises the following steps: Step 1: dissolving L-polylactic acid and D-polylactic acid in volatile organic solvents to prepare oil phase 1 and oil phase 2 with a mass percentage of 5 to 15 wt % respectively; dissolving a surfactant in deionized water to obtain a water phase with a mass percentage of 1 to 5 wt %; Step 2: Load the water phase into the corresponding syringe, use a micro-injection pump for pumping the water phase to inject the water phase into the square tube through the water phase injection needle, load the oil phase 1 and the oil phase 2 into the corresponding syringes respectively, use a micro-injection pump for pumping the oil phase to inject the oil phase 1 and the oil phase 2 into the double-channel injection tube through two oil phase injection needles; at the outlet of the double-channel injection tube, polylactic acid droplets are obtained due to shearing action; Step 3: Collect the prepared polylactic acid droplets through the droplet size adjustment tube, and place them in a room temperature air environment to allow the organic solvent to completely evaporate to obtain polylactic acid microspheres; then wash the polylactic acid microspheres with deionized water for multiple times, and freeze-dry to obtain polylactic acid microspheres of uniform size.

5. The method for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology according to claim 4, characterized in that: The organic solvent is dichloromethane or chloroform.

6. The method for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology according to claim 4, characterized in that: The surfactant is polyvinyl alcohol, polysorbate and polyvinyl pyrrolidone.

7. The method for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology according to claim 4, characterized in that: The flow rate of the oil phase in the dual-channel injection tube is 0.5-1 mL / h, and the flow rate of the water phase in the square tube is 2.5-7.5 mL / min.

8. The method for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology according to claim 4, characterized in that: In the step three, the volatilization time is prolonged, and the content of stereocomplex crystals in the formed polylactic acid microspheres is increased.

9. The method for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology according to claim 4, characterized in that: The first oil phase is prepared by dissolving L-polylactic acid in dichloromethane to obtain a 10 wt % solution, and the second oil phase is prepared by dissolving D-polylactic acid in dichloromethane to obtain a 10 wt % solution.

10. The method for preparing polylactic acid microspheres containing stereocomplex crystals based on microfluidic technology according to claim 7, characterized in that: The flow rate of the oil phase in the dual-channel injection tube is 0.5 mL / h, and the flow rate of the water phase in the square tube is 7.5 mL / min.

Citation Information

Patent Citations

  • Amphiphilic Janus colloidal crystal microsphere and preparation method and application thereof

    CN106117458A

  • Preparation method and preparation device of polymer microspheres

    CN115975225A

  • Device for preparing Double Emulsion with multiple innermost drops enveloped by ultrathin shell, and Double Emulsion thereof

    KR1020150120016A

  • Electric Field-responsive Anisotropic Nano-architectures for Smart Drug Delivery Systems and the Method Thereof

    KR1020180042135A